Article
Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.
Carcinogenesis - 1 Jan 2015
Baumann Francine, Flores Erin, Napolitano Andrea, Kanodia Shreya, Taioli Emanuela, Pass Harvey, Yang Haining, Carbone Michele
Abstract excerpt
BRCA1-associated protein-1 (BAP1) mutations cause a new cancer syndrome, with a high rate of malignant mesothelioma (MM). Here, we tested the hypothesis that MM associated with germline BAP1 mutations has a better prognosis compared with sporadic MM. We compared survival among germline BAP1 mutation MM patients with that of all MM (N = 10 556) recorded in the United States Surveillance, Epidemiology, and End...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
